LASER TREATMENT AND ANTI-PD-1 IMMUNOTHERAPY PROLONG SURVIVAL IN A MOUSE MODEL OF SQUAMOUS CELL CARCINOMAS

被引：0
|
作者：
Christensen, Rikke L.
Omland, Silje H.
Lerche, Catharina M.
Philipsen, Peter A.
Olesen, Uffe H.
Haedersdal, Merete
机构：
[1] Bispebjerg Hosp, Copenhagen, Denmark
[2] Copenhagen Univ Hosp, Dept Dermatol, Copenhagen, Denmark
[3] Copenhagen Univ Hosp, Wound Healing Ctr, Copenhagen, Denmark
来源：
LASERS IN SURGERY AND MEDICINE | 2022年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [41] Treatment of cutaneous squamous cell carcinoma (cSCC) with anti-PD-1 agents: A systematic review and pooled analysis
    Sadowsky, Lauren M.
    Kosche, Cory
    West, Dennis P.
    Choi, Jennifer N.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB288 - AB288
  • [42] Cisplatin plus anti-PD-1 antibody enhanced treatment efficacy in advanced esophageal squamous cell carcinoma
    Lin, Wu
    Qian, Jiong
    Wang, Haohao
    Ren, Ling
    Yang, Yan
    Chen, Chuanzhi
    Chen, Xiangliu
    Huang, Yingying
    Liu, Jin
    Xu, Nong
    Teng, Lisong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (02): : 451 - +
  • [43] Autoimmune diabetes and anti-programmed cell death-1 (anti-PD-1) cancer immunotherapy
    Daltry, S.
    Bujanova, J.
    Cranston, I.
    DIABETIC MEDICINE, 2017, 34 : 102 - 102
  • [44] Colitis due to immunotherapy with anti-PD-1: a case series
    De Ruvo, M.
    Barberio, B.
    Zingone, F.
    Bonanno, L.
    Dal Maso, A.
    Stefano, F.
    Sileni, V. Chiarion
    Savarino, E. V.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 695 - 695
  • [45] Glutamate Modulation Synergizes With Anti-PD-1 Immunotherapy in Glioblastoma
    Medikonda, Ravi
    Choi, John
    Pant, Ayush
    Saleh, Laura
    Routkevitch, Denis
    Tong, Luqing
    Belcaid, Zineb
    Kim, Young H.
    Jackson, Christopher M.
    Mathios, Dimitrios
    Shah, Pavan P.
    Lim, Michael
    NEUROSURGERY, 2020, 67 : 294 - 294
  • [46] Targeting CAFs to Improve Anti-PD-1 Checkpoint Immunotherapy
    Tauriello, Daniele V. F.
    CANCER RESEARCH, 2023, 83 (05) : 655 - 656
  • [47] An affinity threshold for maximum efficacy in anti-PD-1 immunotherapy
    Cowles, Sarah C.
    Sheen, Allison
    Santollani, Luciano
    Lutz, Emi A.
    Lax, Brianna M.
    Palmeri, Joseph R.
    Freeman, Gordon J.
    Wittrup, K. Dane
    MABS, 2022, 14 (01)
  • [48] Innovative cancer immunotherapy, anti-PD-1 antibody Nivolumab
    Shibayama, Shiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S40 - S40
  • [49] Advanced Squamous Cell Carcinoma: Complete Remission to Anti-PD-1 Antibody Therapy
    Gellrich, F. F.
    Beissert, S.
    Meier, F.
    AKTUELLE DERMATOLOGIE, 2019, 45 (05) : 233 - 235
  • [50] Combining Panitumumab With Anti-PD-1 Antibody in Cutaneous Squamous Cell Carcinoma of the Head and Neck After Inadequate Response to Anti-PD-1 Antibody Alone
    Hsu, Emily
    Eton, Omar
    Patel, Akshay, V
    Cartun, Richard
    Earle, Jonathan S.
    Mnayer, Laila O.
    Kotowitz, Jennifer
    Yu, Peter P.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2021, 20 (08) : 901 - 904
12345